Cargando…
Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells
BACKGROUND: Most breast cancers depend on estrogenic growth stimulation. Functional genetic screenings in in vitro cell models have identified genes, which override growth suppression induced by anti-estrogenic drugs like tamoxifen. Using that approach, we have previously identified Breast Cancer An...
Autores principales: | van Agthoven, Ton, Dorssers, Lambert C. J., Lehmann, Ulrich, Kreipe, Hans, Looijenga, Leendert H. J., Christgen, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552740/ https://www.ncbi.nlm.nih.gov/pubmed/26317614 http://dx.doi.org/10.1371/journal.pone.0136845 |
Ejemplares similares
-
Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway
por: Dorssers, Lambert CJ, et al.
Publicado: (2005) -
Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
por: Godinho, M F E, et al.
Publicado: (2010) -
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
por: Godinho, M F E, et al.
Publicado: (2012) -
High frequency of lobular breast cancer in distant metastases to the orbit
por: Raap, Mieke, et al.
Publicado: (2015) -
Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)
por: van Agthoven, Ton, et al.
Publicado: (2016)